Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M K Crow

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
The Journal of Experimental Medicine|October 1, 1991
Characterization of human T cells reactive with the Mycoplasma arthritidis-derived superantigen (MAM): generation of a monoclonal antibody against V beta 17, the T cell receptor gene product expressed by a large fraction of MAM-reactive human T cellsS M Friedman, M K Crow, J R Tumang, et al.
Annals of the Rheumatic Diseases|February 15, 2008
A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathiesM Dastmalchi, C Grundtman, H Alexanderson, et al.
Clinical and Experimental Rheumatology|August 26, 2014
Imatinib mesylate (Gleevec™) in the treatment of diffuse cutaneous systemic sclerosis: results of a 24-month open label, extension phase, single-centre trialJ Gordon, U Udeh, K Doobay, et al.
The Journal of Clinical Investigation|May 1, 1989
Presence of a non-HLA B cell antigen in rheumatic fever patients and their families as defined by a monoclonal antibodyA K Khanna, D R Buskirk, R C Williams, et al.
Osteoarthritis and Cartilage|March 18, 2009
Local cytokine profiles in knee osteoarthritis: elevated synovial fluid interleukin-15 differentiates early from end-stage diseaseC R Scanzello, E Umoh, F Pessler, et al.
Annals of the Rheumatic Diseases|July 16, 2008
Exposure to nuclear antigens contributes to the induction of humoral autoimmunity during tumour necrosis factor alpha blockadeT Cantaert, L De Rycke, C P Mavragani, et al.
Scandinavian Journal of Immunology|May 14, 2016
Autoantibody Specificities and Type I Interferon Pathway Activation in Idiopathic Inflammatory MyopathiesL Ekholm, S Vosslamber, A Tjärnlund, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
The Journal of Experimental Medicine|October 1, 1991
Characterization of human T cells reactive with the Mycoplasma arthritidis-derived superantigen (MAM): generation of a monoclonal antibody against V beta 17, the T cell receptor gene product expressed by a large fraction of MAM-reactive human T cellsS M Friedman, M K Crow, J R Tumang, et al.
Annals of the Rheumatic Diseases|February 15, 2008
A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathiesM Dastmalchi, C Grundtman, H Alexanderson, et al.
Clinical and Experimental Rheumatology|August 26, 2014
Imatinib mesylate (Gleevec™) in the treatment of diffuse cutaneous systemic sclerosis: results of a 24-month open label, extension phase, single-centre trialJ Gordon, U Udeh, K Doobay, et al.
The Journal of Clinical Investigation|May 1, 1989
Presence of a non-HLA B cell antigen in rheumatic fever patients and their families as defined by a monoclonal antibodyA K Khanna, D R Buskirk, R C Williams, et al.
Osteoarthritis and Cartilage|March 18, 2009
Local cytokine profiles in knee osteoarthritis: elevated synovial fluid interleukin-15 differentiates early from end-stage diseaseC R Scanzello, E Umoh, F Pessler, et al.
Annals of the Rheumatic Diseases|July 16, 2008
Exposure to nuclear antigens contributes to the induction of humoral autoimmunity during tumour necrosis factor alpha blockadeT Cantaert, L De Rycke, C P Mavragani, et al.
Scandinavian Journal of Immunology|May 14, 2016
Autoantibody Specificities and Type I Interferon Pathway Activation in Idiopathic Inflammatory MyopathiesL Ekholm, S Vosslamber, A Tjärnlund, et al.
Pageof 7